Trials / Conditions / Neoplasms, Connective and Soft Tissue

Neoplasms, Connective and Soft Tissue

11 registered clinical trials studyying Neoplasms, Connective and Soft Tissue — 2 currently recruiting.

Status	Trial	Sponsor	Phase
Recruiting	Percutaneous Needle Fasciotomy +/- Corticosteroid Injection for Dupuytren's Contracture NCT05440240	Regionshospitalet Silkeborg	Phase 4
Unknown	Neoadjuvant Combination of Doxorubicin, Cisplatin and Methotrexate in Patients Aged 24-40 Years With Primary B NCT05057130	Blokhin's Russian Cancer Research Center	Phase 2 / Phase 3
Terminated	A Study of THE-630 in Patients With Advanced Gastrointestinal Stromal Tumors (GIST) NCT05160168	Theseus Pharmaceuticals	Phase 1 / Phase 2
Unknown	Effect of Negative Pressure Wound Therapy After Surgical Removal of Deep-Seated High-Malignant Soft Tissue Sar NCT04960332	Rigshospitalet, Denmark	N/A
Unknown	Camrelizumab Plus Doxorubicin for the First Line Treatment of Adcanced Soft Tissue Sarcoma NCT04910126	Union Hospital, Tongji Medical College, Huazhong University of Science and Technology	Phase 2
Terminated	A Trial For Participants With Ewing's Sarcoma Treated With Vigil in Combination With Irinotecan and Temozolomi NCT03495921	Gradalis, Inc.	Phase 3
Recruiting	An Electronic Health Record (EHR)-Based Comprehensive Bone and Soft Tissue Tumor Registry NCT02677961	Ohio State University Comprehensive Cancer Center	—
Unknown	Autologous Dendritic Cell Vaccine in Patients With Soft Tissue Sarcoma NCT01883518	N.N. Petrov National Medical Research Center of Oncology	Phase 1 / Phase 2
Terminated	Eltrombopag for the Prevention of Chemotherapy Induced Thrombocytopenia NCT01491594	Duke University	Phase 1
Completed	A Safety Study Utilizing Yondelis and Doxorubicin in Patients With a Type of Cancer Called Soft Tissue Sarcoma NCT00102609	Johnson & Johnson Pharmaceutical Research & Development, L.L.C.	Phase 1
Unknown	Study of Vinorelbine and Cyclofosfamide Among Patients With Refractory Tumours or in Relapse NCT00180947	Gustave Roussy, Cancer Campus, Grand Paris	Phase 2